Project
						Ongoing
						10 Members
			A synthetic glycopeptide for anti-tumor immunotherapy: from design to first use in human
			Sylvie Bay (PI)
			Within the framework of developing a carbohydrate-based vaccine against cancer, we designed and prepared the MAG-Tn3, a fully synthetic immunogen based on the tumor-associated Tn antigen. The MAG-Tn3 is a glycopeptide associating Tn clusters […]